Sanofi Inks Autoimmune Collab That Could Mean $0.5B in Payments for ImmuNext – Genetic Engineering and Biotechnology News

Read article - Quotes Randolph Noelle, professor of microbiology and immunology, in an article about how ImmuNext, a company he co-founded, entered into an agreement with Sanofi to develop a novel protein for the treatment of autoimmune disorders.